Target intelligence / Profile preview

Ammonia (NH3) (NH3)

Target
NH3
Molecular classification
Metabolite, Small molecule
01

Overview

Ammonia is a small nitrogenous molecule primarily produced in the gastrointestinal tract through the bacterial degradation of nitrogen-containing compounds and the hydrolysis of urea by microbial ureases (Source: PubChem, CID 222). In healthy physiology, gut-derived ammonia is transported via the portal vein to the liver, where it is converted into urea for renal excretion; however, in patients with cirrhosis or urea cycle disorders, this clearance mechanism fails, leading to systemic hyperammonemia (Source: StatPearls, NBK537209). Elevated ammonia levels are neurotoxic, as the molecule readily crosses the blood-brain barrier, causing astrocyte swelling and contributing to the clinical syndrome of hepatic encephalopathy (Source: J Clin Exp Hepatol, 2015). Therapeutic strategies target ammonia in the gut lumen to prevent its absorption, utilizing non-absorbable disaccharides like lactulose to acidify the environment and trap ammonia as ammonium ions (NH4+), or antibiotics like rifaximin to reduce the population of ammonia-producing bacteria (Source: LiverTox, NBK548059). Consequently, managing the gut ammonia pool is a fundamental approach to treating metabolic and neurological complications associated with liver failure.

Other names
Gut ammoniaIntestinal ammoniaAmmonium ionNH4+
02

Mechanism of action

Reduction of ammonia production by gut bacteria and acidification of the gut lumen to trap ammonia as non-absorbable ammonium ions.

03

Biological functions

Nitrogen metabolismProtein catabolismpH regulation
04

Disease associations

Hepatic encephalopathyHyperammonemiaLiver cirrhosisUrea cycle disorder
05

Safety considerations

Electrolyte imbalanceDehydrationGastrointestinal distressAntibiotic resistance
06

Interacting drugs

Lactulose

5 more in the full profile.

07

Biomarkers

Plasma ammonia concentrationWest Haven Criteria for hepatic encephalopathyPsychometric Hepatic Encephalopathy Score (PHES)

Beyond the preview

Go deeper on Ammonia (NH3) (NH3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ammonia (NH3) (NH3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call